China Resources pharmaceutical (03320.HK) announced that its subsidiary CR Sci Pharmaceutical received the 'Drug Supplementary Application Approval Notice' for Amlodipine Atorvastatin Calcium Tablets from the National Medical Products Administration.

Amlodipine Atorvastatin Calcium Tablets are suitable for patients who require combined therapy of Amlodipine and Atorvastatin. Among them, Amlodipine is used for the treatment of hypertension, stable chronic angina, vasospastic angina, and confirmed coronary heart disease by angiography; Atorvastatin is used for the treatment of hypercholesterolemia and coronary heart disease.